CHD4 and NKX2.2 Cooperate to Regulate Beta Cell Function by Repressing Non-Beta Cell Gene Programs

NKX2.2 is a transcription factor that regulates pancreatic islet beta ({beta}) cell identity and function; however, cofactor proteins that modulate the functional activity of NKX2.2 in {beta} cells are relatively unexplored. An unbiased proteomics screen identified chromodomain helicase DNA-binding protein 4 (CHD4) as an NKX2.2 interacting partner. CHD4 is a nucleosome remodeler that directs the appropriate differentiation, maturation and function of many cell types. To characterize the roles of CHD4 in {beta} cells, we generated Chd4 {beta}KO mice. Deletion of Chd4 substantially impaired the function of {beta} cells. The Chd4 {beta}KO mice became diabetic due to the disruption of islet integrity, calcium signaling and downregulation of essential {beta} cell regulatory genes. We also discovered CHD4 is required to bind at and repress non-beta cell genes, including Kcnj5, the gene that encodes the GIRK4 potassium channel in {beta} cells. Aberrant upregulation of GIRK4 causes impaired glucose-stimulated insulin secretion. These studies demonstrate that CHD4 is an essential transcriptional cofactor of NKX2.2 that is required for the proper maturation and function of pancreatic {beta} cells. Article HighlightsO_LINKX2.2 interacts with the Nucleosome Remodeling and Deacetylase (NuRD) complex through its interaction with CHD4. C_LIO_LIDeletion of CHD4 from developing pancreatic {beta} cells in mice causes diabetes due to a loss of islet integrity, disrupted calcium signaling and impaired insulin secretion. C_LIO_LIBeta cells lacking CHD4 inappropriately upregulate the GIRK4 potassium channel; inhibition of GIRK4 rescues the insulin secretion defect. C_LI